United States · Health Care · USD (Thousands) · Annual
Reported figures and Equlion model projections for the next 5 years.
Sector average (own scale)
Sector average (own scale)
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for Instil Bio, Inc.? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | ||||
|---|---|---|---|---|---|---|
| Metric | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
| ROE | -50.39% | -89.05% | -929.21% | 114.28% | 55.79% | 40.24% |
|---|---|---|---|---|---|---|
| Sector average | 22.99% | 73.17% | 65.88% | 68.36% | 41.61% | 44.34% |
| ROA | -30.56% | -35.04% | -36.54% | -38.22% | -40.67% | -46.97% |
| Total Assets | $203,523.00K | $196,885.00K | $196,885.00K | $196,885.00K | $196,885.00K | $196,885.00K |
| Sector average | $3,516,665.42K | $3,537,396.33K | $3,954,880.66K | |||
| Net Income | -$71,372.00K | -$70,158.13K | -$71,933.16K | -$75,254.36K | -$80,071.15K | -$92,474.90K |
| $4,602,556.36K |
| $5,424,035.31K |
| $6,260,073.84K |